Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients

AIM: To survey the efficacy and safety of dual therapy with daclatasvir and asunaprevir in the elderly hepatitis C virus (HCV) patients multicentricity. METHODS: Interferon-ineligible/intolerant patients and non-responders to previous pegylated-interferon/ribavirin therapy with chronic HCV genotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarao, Kazuo, Tanaka, Katsuaki, Nozaki, Akito, Sato, Akira, Ishii, Toshiya, Komatsu, Hirokazu, Ikeda, Takaaki, Komatsu, Tatsuji, Matsushima, Shozo, Oshige, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395803/
https://www.ncbi.nlm.nih.gov/pubmed/28469810
http://dx.doi.org/10.4254/wjh.v9.i11.544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395803/
https://www.ncbi.nlm.nih.gov/pubmed/28469810
http://dx.doi.org/10.4254/wjh.v9.i11.544

Ejemplares similares